True NorthHealth Labs Build
Peptide Answers

compound

Survodutide (10mg Vial) Questions Answered

Survodutide (BI 456906) is a dual glucagon/GLP‑1 receptor agonist investigated for obesity and related metabolic conditions.

Read full protocol Calculate dose Find supplies TNHL ebooks
Educational reference only. TNHL does not diagnose, prescribe, or replace care from a licensed professional. Confirm all dosing, contraindications, and product decisions with qualified guidance.
Direct answer

Survodutide (10mg Vial)

Week Daily Dose (mcg) Units (per injection) (mL) Weeks 1–4 600 mcg 12 units (0.12 mL) Weeks 5–8 1200 mcg 24 units (0.24 mL) Weeks 9–12 1800 mcg 36 units (0.36 mL) Weeks 13–16 2400 mcg 48 units (0.48 mL) Weeks 17–20 (optional escalation) 3600 mcg 72 units (0...

Quickstart Highlights

Survodutide (BI 456906) is a dual glucagon/GLP‑1 receptor agonist investigated for obesity and related metabolic conditions.

Standard / Gradual Approach (2.0 mL = ~5.00 mg/mL)

Week Daily Dose (mcg) Units (per injection) (mL) Weeks 1–4 600 mcg 12 units (0.12 mL) Weeks 5–8 1200 mcg 24 units (0.24 mL) Weeks 9–12 1800 mcg 36 units (0.36 mL) Weeks 13–16 2400 mcg 48 units (0.48 mL) Weeks 17–20 (optional escalation) 3600 mcg 72 units (0...

Supplies Needed

Plan based on an 8–16 week once‑weekly titration anchored to clinical trial dosing ranges [1] .

Storage Instructions

Proper storage preserves peptide stability. Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions.